Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Biobehavioral influences on recovery following hematopoietic stem cell transplantation.

Costanzo ES, Juckett MB, Coe CL.

Brain Behav Immun. 2013 Mar;30 Suppl:S68-74. doi: 10.1016/j.bbi.2012.07.005. Epub 2012 Jul 20. Review.

3.

Immune restoration following hematopoietic stem cell transplantation: an evolving target.

Auletta JJ, Lazarus HM.

Bone Marrow Transplant. 2005 May;35(9):835-57. Review.

PMID:
15778723
4.

Transplantation of CD34+ hematopoietic precursors: clinical rationale.

Berenson RJ.

Transplant Proc. 1992 Dec;24(6):3032-4. Review. No abstract available.

PMID:
1281584
5.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
6.

Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.

Bouchlaka MN, Redelman D, Murphy WJ.

Immunotherapy. 2010 May;2(3):399-418. doi: 10.2217/imt.10.20. Review.

7.

Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways.

Knight JM, Lyness JM, Sahler OJ, Liesveld JL, Moynihan JA.

Psychoneuroendocrinology. 2013 Nov;38(11):2383-93. doi: 10.1016/j.psyneuen.2013.06.016. Epub 2013 Jul 8. Review.

8.

Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?

Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T.

Chimerism. 2013 Jul-Sep;4(3):78-83. doi: 10.4161/chim.25609. Epub 2013 Jul 11. Review.

9.

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.

Servais S, Baron F, Beguin Y.

Transfus Apher Sci. 2011 Apr;44(2):205-10. doi: 10.1016/j.transci.2011.01.019. Epub 2011 Feb 22. Review.

PMID:
21345734
10.

Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.

Maloney DG.

Leuk Lymphoma. 2003;44 Suppl 3:S99-105. Review.

PMID:
15202532
12.

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

Sprangers B, Van Wijmeersch B, Fevery S, Waer M, Billiau AD.

Nat Clin Pract Oncol. 2007 Jul;4(7):404-14. Review.

PMID:
17597705
13.

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

Gribben JG, Hosing C, Maloney DG.

Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S63-70. doi: 10.1016/j.bbmt.2010.10.011. Review.

15.

[Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].

Fu HX, Zhang XH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):222-6. Review. Chinese.

PMID:
18315936
16.

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.

André-Schmutz I, Dal Cortivo L, Fischer A, Cavazzana-Calvo M.

Cytotherapy. 2005;7(2):102-8. Review.

PMID:
16040389
17.

The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Newman RG, Ross DB, Barreras H, Herretes S, Podack ER, Komanduri KV, Perez VL, Levy RB.

Immunol Res. 2013 Dec;57(1-3):125-39. doi: 10.1007/s12026-013-8450-7. Review.

PMID:
24272856
18.

The role of T cells in hematopoietic stem cell engraftment.

Hexner E.

ScientificWorldJournal. 2006 Feb 26;6:246-53. Review.

19.

Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective.

Eapen M, Rocha V.

Lifetime Data Anal. 2008 Dec;14(4):379-88. doi: 10.1007/s10985-008-9090-4. Epub 2008 Jul 8. Review.

PMID:
18607725
20.
Items per page

Supplemental Content

Write to the Help Desk